Location: Boston, MA
CIK: 0001082621 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 13, 2021
Total Value: $1.738B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 2,434,903 | $333M | 19.2% | $136.96 | — | — | COM | 037833100 |
| RPRX | ROYALTY PHARMA PLC | 7,142,856 | $293M | 16.8% | $40.99 | — | — | SHS CLASS A | G7709Q104 |
| LNWO | SCIENTIFIC GAMES CORP | 2,678,571 | $207M | 11.9% | $77.44 | — | — | COM | 80874P109 |
| META | FACEBOOK INC | 519,456 | $181M | 10.4% | $347.71 | — | — | CL A | 30303M102 |
| PANW | PALO ALTO NETWORKS INC | 245,943 | $91.26M | 5.3% | $371.05 | — | — | COM | 697435105 |
| ABCL | ABCELLERA BIOLOGICS INC | 4,105,095 | $90.31M | 5.2% | $22.00 | — | — | COM | 00288U106 |
| ICE | INTERCONTINENTAL EXCHANGE IN | 688,549 | $81.73M | 4.7% | $118.70 | — | — | COM | 45866F104 |
| RXRX | RECURSION PHARMACEUTICALS IN | 1,509,254 | $55.09M | 3.2% | $36.50 | — | — | CL A | 75629V104 |
| DVA | DAVITA INC | 408,912 | $49.24M | 2.8% | $120.43 | — | — | COM | 23918K108 |
| TXG | 10X GENOMICS INC | 186,143 | $36.45M | 2.1% | $195.82 | — | — | CL A COM | 88025U109 |
| QQQ | INVESCO QQQ TR | 102,222 | $36.23M | 2.1% | $354.43 | — | — | UNIT SER 1 | 46090E103 |
| AFRM | AFFIRM HLDGS INC | 477,421 | $32.15M | 1.9% | $67.35 | — | — | COM CL A | 00827B106 |
| IVV | ISHARES TR | 65,342 | $28.09M | 1.6% | $429.92 | — | — | CORE S&P500 ETF | 464287200 |
| PCT | PURECYCLE TECHNOLOGIES INC | 1,069,600 | $25.3M | 1.5% | $23.65 | — | — | COM | 74623V103 |
| RVMD | REVOLUTION MEDICINES INC | 670,382 | $21.28M | 1.2% | $31.74 | — | — | COM | 76155X100 |
| U | UNITY SOFTWARE INC | 186,396 | $20.47M | 1.2% | $109.83 | — | — | COM | 91332U101 |
| RLAY | RELAY THERAPEUTICS INC | 541,124 | $19.8M | 1.1% | $36.59 | — | — | COM | 75943R102 |
| PLRX | PLIANT THERAPEUTICS INC | 562,379 | $16.38M | 0.9% | $29.12 | — | — | COM | 729139105 |
| GLD | SPDR GOLD TR | 91,955 | $15.23M | 0.9% | $165.64 | — | — | GOLD SHS | 78463V107 |
| — | PRAXIS PRECISION MEDICINES I | 778,517 | $14.23M | 0.8% | $18.28 | — | — | COM | 74006W108 |
| — | GENERATION BIO CO | 512,349 | $13.78M | 0.8% | $26.90 | — | — | COM | 37148K100 |
| — | KINNATE BIOPHARMA INC | 498,001 | $11.59M | 0.7% | $23.28 | — | — | COM | 49705R105 |
| SANA | SANA BIOTECHNOLOGY INC | 468,749 | $9.216M | 0.5% | $19.66 | — | — | COM | 799566104 |
| VEA | VANGUARD TAX-MANAGED INTL FD | 162,699 | $8.382M | 0.5% | $51.52 | — | — | FTSE DEV MKT ETF | 921943858 |
| NRIX | NURIX THERAPEUTICS INC | 314,762 | $8.351M | 0.5% | $26.53 | — | — | COM | 67080M103 |
| IJR | ISHARES TR | 50,474 | $5.703M | 0.3% | $112.99 | — | — | CORE S&P SCP ETF | 464287804 |
| FULC | FULCRUM THERAPEUTICS INC | 410,714 | $4.304M | 0.2% | $10.48 | — | — | COM | 359616109 |
| VWO | VANGUARD INTL EQUITY INDEX F | 73,804 | $4.008M | 0.2% | $54.31 | — | — | FTSE EMR MKT ETF | 922042858 |
| — | FS DEVELOPMENT CORP II | 400,000 | $4M | 0.2% | $10.00 | — | — | COM CL A | 30318F100 |
| IJH | ISHARES TR | 12,683 | $3.408M | 0.2% | $268.71 | — | — | CORE S&P MCP ETF | 464287507 |
| — | MAGENTA THERAPEUTICS INC | 332,610 | $3.253M | 0.2% | $9.78 | — | — | COM | 55910K108 |
| PDD | PINDUODUO INC | 25,493 | $3.238M | 0.2% | $127.02 | — | — | SPONSORED ADS | 722304102 |
| — | SERES THERAPEUTICS INC | 131,847 | $3.145M | 0.2% | $23.85 | — | — | COM | 81750R102 |
| — | DECIBEL THERAPEUTICS INC | 328,798 | $2.828M | 0.2% | $8.60 | — | — | COM | 24343R106 |
| DYN | DYNE THERAPEUTICS INC | 107,252 | $2.257M | 0.1% | $21.04 | — | — | COM | 26818M108 |
| — | GEMINI THERAPEUTICS INC | 250,000 | $1.618M | 0.1% | $6.47 | — | — | COM | 36870G105 |
| — | NUCANA PLC | 387,124 | $1.072M | 0.1% | $2.77 | — | — | SPONSORED ADR | 67022C106 |
| QNCX | CORTEXYME INC | 2,937 | $156K | 0.0% | $53.12 | — | — | COM | 22053A107 |